San Diego Business Journal

Local Biotech Co.’s Success Fuels Optimism in IPO Market

FINANCE: AnaptysBio Still Trading at Premium; Other Firms Lining Up By Sarah de Crescenzo Originally published April 13, 2017 at 1:53 p.m., updated April 13, 2017 at 1:53 p.m.


Tim Holl

— One initial public offering may not sound like much, but the January debut of San Diego biotech AnaptysBio Inc...

Take 1 minute to subscribe and you’ll get this story immediately, plus:

Already a subscriber? Sign in

  • 51 weekly issues: $153 value
  • Subscriber-only digital content every business day, plus full access to archives: $150 value
  • Book of Lists — the biggest, hottest companies in San Diego: $75 value
  • NEW: San Diego 500 — influential business leaders you need to know: $50 value
  • Total Package Value: $428

Yours for only $129